FDA targets two ED products (Nutraingredients.com)
5/15/2007 - The credibility of dietary supplement products supporting erectile dysfunction (ED) will not likely be enhanced by the US Food & Drug Administration's release of a health risk alert pertaining to two products.

St. Jude Medical Announces FDA Approvals of Current ICD and Promote CRT-D Heart Failure Devices (RedNova)
St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) approval of its newest devices for treating patients with potentially lethal heart arrhythmias and heart failure.

Lupin Receives US FDA Approval for Simvastatin Tablets (PR Newswire via Yahoo! Finance)
Lupin Pharmaceuticals, Inc. announced today that it has received final approval from the US FDA for its Abbreviated New Drug Application for Simvastatin Tablets 10mg, 20mg, 40mg and 80mg.